(Q39280262)

English

Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period

scientific article published on 6 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period (English)

1 reference

Europe PubMed Central

10 September 2017

1 reference

based on heuristic

inferred from title

author name string

Hala Abou Hammoud

1

1 reference

Europe PubMed Central

10 September 2017

Guy Aymard

2

1 reference

Europe PubMed Central

10 September 2017

Philippe Lechat

3

1 reference

Europe PubMed Central

10 September 2017

Nicolas Boccheciampe

4

1 reference

Europe PubMed Central

10 September 2017

Bruno Riou

5

1 reference

Europe PubMed Central

10 September 2017

Frédéric Aubrun

6

1 reference

Europe PubMed Central

10 September 2017

publication date

6 September 2010

1 reference

Europe PubMed Central

10 September 2017

Fundamental and Clinical Pharmacology

1 reference

Europe PubMed Central

10 September 2017

25

1 reference

Europe PubMed Central

10 September 2017

4

1 reference

Europe PubMed Central

10 September 2017

518-527

1 reference

Europe PubMed Central

10 September 2017

Pharmacokinetic optimisation of opioid treatment in acute pain therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Postoperative titration of intravenous morphine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Sex- and age-related differences in morphine requirements for postoperative pain relief

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Postoperative titration of intravenous morphine in the elderly patient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Mu receptor binding of some commonly used opioids and their metabolites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Randomized placebo-controlled trial of the activity of the morphine glucuronides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Limited phase I study of morphine-3-glucuronide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Relationships among morphine metabolism, pain and side effects during long-term treatment: an update.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Systematic review of factors affecting the ratios of morphine and its major metabolites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Controlled Sedation with Alphaxalone-Alphadolone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

LC determination of morphine and morphine glucuronides in human plasma by coulometric and UV detection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Postoperative morphine consumption in the elderly patient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Morphine metabolites as novel analgesic drugs?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Opioid metabolites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Role of active metabolites in the use of opioids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Preemptive intravenous morphine-6-glucuronide is ineffective for postoperative pain relief

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Is morphine-induced sedation synonymous with analgesia during intravenous morphine titration?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Opioid-induced sedation in the postanesthesia care unit does not insure adequate pain relief: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Long lasting respiratory depression induced by morphine-6-glucuronide?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Morphine-3-glucuronide: silent regulator of morphine actions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Opioid-induced hyperalgesia: abnormal or normal pain?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Antinociceptive and nociceptive actions of opioids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Is morphine-3-glucuronide of therapeutic relevance?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Genetic variability of mu-opioid receptor in an obstetric population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Improved One-Step Solid-Phase Extraction Method for Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide From Plasma and Quantitation Using High-Performance Liquid Chromatography With Electrochemical Detection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00867.X

21 January 2018

Identifiers

10.1111/J.1472-8206.2010.00867.X

1 reference

Europe PubMed Central

10 September 2017

release_3kmopsxoovbehjl6gazzzs3w5i

0 references

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39280262&oldid=1817998905"